Various reports have shown that cannabinoids (the active components of marijuana and
their derivatives) can reduce tumour growth and progression in animal models of cancer, in …

In addition to the well-known palliative effects of cannabinoids on some cancer-associated
symptoms, a large body of evidence shows that these molecules can decrease tumour …

Cannabinoids—the active components of Cannabis sativa and their derivatives—exert
palliative effects in cancer patients by preventing nausea, vomiting and pain and by …

In the last two decades, research has dramatically increased the knowledge of cannabinoids
biology and pharmacology. In mammals, compounds with properties similar to active …

Cannabinoids have been attracting a great deal of interest as potential anticancer agents.
Originally derived from the plant Cannabis sativa, there are now a number of endo-, phyto …

Cannabinoids are a class of pharmacologic compounds that offer potential applications as
antitumor drugs, based on the ability of some members of this class to limit inflammation, cell …

Drugs that target the endocannabinoid system are of interest as pharmacological options to
combat cancer and to improve the life quality of cancer patients. From this perspective …

To date, cannabinoids have been allowed in the palliative medicine due to their analgesic
and antiemetic effects, but increasing number of preclinical studies indicates their anticancer …

Cannabinoids (the active components of Cannabis sativa) and their derivatives have
received renewed interest in recent years due to their diverse pharmacological activities. In …

Introduction Cannabinoids are a group of terpenophenolic compounds derived from the
Cannabis sativa L. plant. There is a growing body of evidence from cell culture and animal …